Evidence map›Paper›PMID 38265970›Full record

Trial reportCancer2024

Effect of home-based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial.

Bette J Caan, Justin C Brown, Catherine Lee, Alexandra M Binder, Erin Weltzien, Michelle C Ross, Charles P Quesenberry, Kristin L Campbell, Elizabeth M Cespedes Feliciano, Adrienne Castillo and 4 more

Open access · bronzeAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Review
  12. Review
  13. Article
  14. Response to McGovern, Dolan, Skipworth, et al.Journal of the National Cancer Institute · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Bette J CaanDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.ORCID https://orcid.org/0000-0002-5803-310X
Justin C BrownCancer Metabolism Program, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.ORCID https://orcid.org/0000-0002-0602-3284
Catherine LeeDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Alexandra M BinderCancer Epidemiology, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Erin WeltzienDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Michelle C RossDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Charles P QuesenberryDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Kristin L CampbellDepartment of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0002-2266-1382
Elizabeth M Cespedes FelicianoDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.ORCID https://orcid.org/0000-0003-1192-4017
Adrienne CastilloDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Sara QuinneyIndiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Shengping YangCancer Metabolism Program, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Jeffrey A MeyerhardtDana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kathryn H SchmitzDivision of Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-2400-2935
Kaiser Permanente · USPennington Biomedical Research Center · USDana-Farber Cancer Institute · USIndiana University School of MedicineUniversity of British Columbia · CAUniversity of Hawaiʻi at Mānoa · USUniversity of Pittsburgh · US

Funding

Resistance Training to Reduce Chemotoxicity in Colon CancerR01CA206196 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CAAN, BETTE J, MEYERHARDT, JEFFREY A · 2017 to 2021
$4.1M
D3-creatine dilution to determine skeletal muscle mass in colon cancer patientsR01CA240394 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI FELICIANO, ELIZABETH MARJORIE CESPEDES · 2020 to 2023
$1.5M
NCI NIH HHS R01 CA206196NCI NIH HHS R01CA206196NCI NIH HHS R01 CA240394
6 · The paper itself

Abstract

backgroundMany patients with colon cancer cannot fully adhere to postoperative chemotherapy due to dose-limiting toxicities, resulting in lower relative dose intensity (RDI) and potentially compromising overall survival. This study examined whether home-based resistance training (RT) during adjuvant chemotherapy improves RDI and patient-reported toxicities versus usual care (UC) in colon cancer patients.

methodsMulticenter, randomized control trial (RCT) conducted at community and academic practices. Enrollment of patients receiving postoperative chemotherapy for colon cancer occurred between February 23, 2018, and September 29, 2021; final follow-up was March 21, 2022. Participants were randomized to RT (n = 90) or UC (n = 91) for the duration of chemotherapy. Participants in the RT group engaged in twice weekly home-based progressive RT. At the end of the study, UC was given an online exercise program.

resultsAmong 181 randomized patients (mean age, 55.2 [SD, 12.8] years, 95 [52.5%] were men), there were no differences in the mean RDI among those in RT (79% [SD, 19%]) and those in UC (82% [SD, 19%]); (mean difference -0.04 [95% confidence interval (CI), -0.09 to 0.02]). Assignment to RT did not significantly reduce the number of moderate/severe symptoms per week across follow-up (relative rate: 0.94 [95% CI, 0.72-1.22]). Additionally, time since randomization did not significantly modify the effect of RT on the overall number of symptoms (p = .06).

conclusionsAmong patients with colon cancer, these results do not support home-based RT as an adjunct to chemotherapy specifically to improve planned treatment intensity.

Indexed as

Colonic NeoplasmsResistance TrainingAdultAgedAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantFemaleHumansMaleMiddle Agedcolon cancerexerciserandomized trialrelative dose intensity

Identifiers

PMID38265970
PMCPMC11058014
OpenAlexW4391166648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.